Back to News
Market Impact: 0.2
Ultragenyx (RARE) Surges 12.6%: Is This an Indication of Further Gains?
Source: zacks.com
Healthcare & BiotechAnalyst EstimatesMarket Technicals & Flows
Ultragenyx (RARE) recorded an outsized move in the prior session alongside above-average trading volume. The article indicates that favorable earnings-estimate revision trends could support further near-term upside, though it provides no specific price, volume, or estimate-revision figures.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
RARE0.35
More News
- Canaccord raises Ultragenyx stock price target on gene therapy approval
- Cantor Fitzgerald raises Ultragenyx stock price target on gene therapy approval
- Stocks face a key hurdle in next week’s U.S.-China summit. Here’s what’s at stake
- Japan has record 100,000 people aged over 100: How societies are ageing
- Bank of Japan Hikes Interest Rates in a Split Vote; Yen Drops
- Tokenization is set to change stock trading. These stocks could get a boost